Exactech, Inc. develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians in the United States and internationally. The Company's operating segments are represented by its major product lines: knee implants, hip implants, biologics and spine, extremity implants and other products. Its other products segment includes miscellaneous sales categories, such as surgical instruments held for sale, bone cement, instrument rental fees, shipping charges, and other implant product lines. The Company manufactures some components of its knee, extremity, and hip joint replacement systems at its facility in Gainesville, Florida. Its joint replacement products are used by orthopedic surgeons to repair or replace joints that have deteriorated as a result of injury or disease. Its spinal implants are used as an adjunct to the fusion of vertebrae in the treatment of spinal disease and deformity.
Exactech was founded in 1985 and is headquartered in Gainesville, US
Exactech Office Locations
Exactech has offices in Gainesville, Capinghem, Bella Vista, Chūō-ku and in 10 other locations
Gainesville, US (HQ)
2320 Nw 66 Ct
Ostwald, FR
Rue D'illkirch
Redditch, GB
Grosvenor House Prospect Hill
Kiel, DE
193 Werftstraße
Zhubei City, TW
2 Section 2, Shengyi Rd
Caledonia, CA
322 Argyle St S
Bern, CH
5 Weltpoststrasse
La Tronche, FR
5 Avenue Du Grand Sablon
Chūō Ku, JP
第２三木ビル
Bella Vista, AU
2 14 Lexington Dr
Capinghem, FR
Rue De La Zamin
Exactech Data and Metrics
Exactech Financial Metrics
Exactech's revenue was reported to be $257.6 m in FY, 2016
Numbers are in $, USD
Revenue (FY, 2016) | 257.6 m |
Revenue growth (FY, 2015 - FY, 2016), % | 7% |
Gross profit (FY, 2016) | 177.3 m |
Gross profit margin (FY, 2016), % | 69% |
Net income (FY, 2016) | 162 k |
EBIT (FY, 2016) | 7.6 m |
Market capitalization (22-Jun-2017) | 443 m |
Closing share price (22-Jun-2017) | 30.4 |
Cash (31-Dec-2016) | 13.1 m |
EV | 449.9 m |
Exactech's current market capitalization is $443 m.
- Source: SEC Filings
| Numbers are in $, USD | FY, 2013 | FY, 2014 | Y, 2015 | FY, 2016 |
|---|---|---|---|---|
Revenue | 237.1 m | 248.4 m | 241.8 m | 257.6 m |
Revenue growth, % | 5% | (3%) | 7% | |
Cost of goods sold | 73 m | 74.2 m | 73.6 m | 80.3 m |
Gross profit | 164.1 m | 174.1 m | 168.2 m | 177.3 m |
Gross profit Margin, % | 69% | 70% | 70% | 69% |
Operating expense total | 140.1 m | 147.9 m | 145.9 m | 169.7 m |
EBIT | 23.9 m | 26.3 m | 22.3 m | 7.6 m |
EBIT margin, % | 10% | 11% | 9% | 3% |
Interest expense | 1.2 m | 1.1 m | 1.3 m | 1 m |
Interest income | 8 k | 16 k | 9 k | 15 k |
Net Income | 15.4 m | 16.5 m | 14.8 m | 162 k |
- Source: SEC Filings
| Numbers are in $, USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Cash | 6 m | 10.1 m | 12.7 m | 13.1 m |
Accounts Receivable | 59.1 m | 50.7 m | 52.4 m | 53.1 m |
Inventories | 71.6 m | 72.8 m | 71.4 m | 65.3 m |
Current Assets | 142.6 m | 139.2 m | 141.4 m | 143.1 m |
Goodwill | 13.5 m | 13.1 m | 18.9 m | 13.8 m |
Total Assets | 261.8 m | 261 m | 277.2 m | 294.2 m |
Accounts Payable | 16.3 m | 13.6 m | 13.9 m | 17.6 m |
Total Debt | 26.3 m | 23.3 m | 20 m | |
Current Liabilities | 30.5 m | 26.2 m | 24.8 m | 33.1 m |
Non-Current Liabilities | 38.9 m | 23.5 m | 24 m | 26.9 m |
Total Liabilities | 69.4 m | 49.7 m | 48.9 m | 60 m |
Additional Paid-in Capital | 69.2 m | 76.1 m | 82 m | 87.3 m |
Retained Earnings | 127 m | 143.5 m | 158.3 m | 158.4 m |
Total Equity | 192.4 m | 211.4 m | 228.4 m | 234.2 m |
Debt to Equity Ratio | 0.1 x | 0.1 x | 0.1 x | |
Debt to Assets Ratio | 0.1 x | 0.1 x | 0.1 x | |
Financial Leverage | 1.4 x | 1.2 x | 1.2 x | 1.3 x |
| Numbers are in $, USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Net Income | 15.4 m | 16.5 m | 14.8 m | 162 k |
Depreciation and Amortization | 17.6 m | 18.5 m | 16.9 m | 18 m |
Accounts Receivable | (11 m) | 6.4 m | (3.1 m) | (2.1 m) |
Inventories | (9.7 m) | (9.1 m) | (6.9 m) | (16 m) |
Accounts Payable | 910 k | (2.7 m) | (1.2 m) | 2.4 m |
Cash From Operating Activities | 16.7 m | 32 m | 28.1 m | 30 m |
Purchases of PP&E | (15.3 m) | (18.2 m) | (19.5 m) | (30.1 m) |
Cash From Investing Activities | (15.7 m) | (18.6 m) | (20.5 m) | (33.7 m) |
Cash From Financing Activities | (751 k) | (8.8 m) | (4.7 m) | 4.2 m |
Interest Paid | 1 m | 1.1 m | 878 k | 574 k |
Income Taxes Paid | 8.9 m | 9.2 m | 7.4 m | 9.4 m |
| Y, 2016 | |
|---|---|
EV/EBIT | 59 x |
EV/CFO | 15 x |
Debt/Equity | 0.1 x |
Debt/Assets | 0.1 x |
Financial Leverage | 1.3 x |
